NCT00194324|CompletedPhase 4
Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina
Vaginal Imaging Study to Evaluate the Effect of Exercise on the Distribution of Miconozole Nitrate OVULE
Loading search results
Vaginal Imaging Study to Evaluate the Effect of Exercise on the Distribution of Miconozole Nitrate OVULE
Sponsor study identifier
Secondary identifiers
interventional
12
1 country
1
Study Start
July 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
October 2004
Actual (reported)This study uses MRI to detect the spread of the Miconozole Nitrate OVULE within the vagina. The effect of moderate amounts of physical activity on the spread will be evaluated, and compared to no physical activity.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2004
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2004
Date type not reportedThis date has not been verified as actual or estimated.
October 2004
Actual (reported)September 13, 2005
Actual (reported)September 19, 2005
Actual (reported)To compare between exercise and no exercise:
Time needed for the capsule to dissolve;
Quantify and describe product distribution at 20 minute intervals within the first 90 minutes after insertion;
Quantify systemic levels of miconozole nitrate 90 minutes and 24 hours after insertion;
Quantify amount of miconozole nitrate in the vagina 90 minutes and 24 hours after insertion
Product distribution will be assessed by:
Linear spread from the cervix covered by the product;
Percent of maximal linear spread from the cervix;
Surface area covered by the product;
Percent of maximal surface contact;
University of Pennsylvania Reproductive Research Unit
Philadelphia, Pennsylvania, 19104, United States
Kurt T Barnhart, MD, MSCE
University of Pennsylvania
First Submitted
September 13, 2005
First Posted
September 19, 2005
Study Start
July 2004
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
October 2004
Actual (reported)Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Last Updated
August 9, 2011
Record last verified: 2011-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: